24/7 Market News Snapshot 03 March, 2025 – Senseonics Holdings, Inc. (NYSE:SENS)

March 3, 2025

DENVER, Colo., 03 March, 2025 (247marketnews.com) – (NYSE:SENS) are discussed in this article.
Senseonics Holdings, Inc. has opened trading at $0.96, currently sitting at approximately $0.965, representing a notable increase of 13.53% from the previous close of $0.85. This rise is backed by a trading volume of 87.48K shares, reflecting heightened market interest and suggesting positive investor sentiment. Factors contributing to this upward movement could include favorable developments in the biotech sector, warranting traders to assess key resistance levels and overall market dynamics for evaluating the sustainability of this bullish trend. Increased trading volume might support continued momentum, while a decrease could indicate potential profit-taking.

The company also recently celebrated a significant achievement with the FDA’s approval and the U.S. launch of its Eversense® 365 Continuous Glucose Monitoring (CGM) system, which is designed to improve diabetes management for patients with Type 1 and Type 2 diabetes. The Eversense 365 system is establishing itself as a key player in the market, leading to a 56% increase in the patient base in 2024, surpassing 6,000 users globally. December marked a record-setting month for the company, with over 600 new patient shipments, highlighting the system’s growing popularity amidst its competitors.

Financial results for the fourth quarter showed revenues of $8.3 million, maintaining steady growth compared to the prior year, while operational efficiency led to improved profit margins despite a net loss of $15.5 million for the quarter. The outlook for 2025 is optimistic, with plans to double the patient base and projected global net revenue between $34 million and $38 million. Senseonics remains steadfast in its mission to revolutionize diabetes care, positioning itself as a leader in continuous glucose monitoring solutions.

Related news for (SENS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.